CO6940375A2 - Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo - Google Patents

Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo

Info

Publication number
CO6940375A2
CO6940375A2 CO13301122A CO13301122A CO6940375A2 CO 6940375 A2 CO6940375 A2 CO 6940375A2 CO 13301122 A CO13301122 A CO 13301122A CO 13301122 A CO13301122 A CO 13301122A CO 6940375 A2 CO6940375 A2 CO 6940375A2
Authority
CO
Colombia
Prior art keywords
lysiloxidase
homologue
test
methods
Prior art date
Application number
CO13301122A
Other languages
English (en)
Inventor
Victoria Smith
Joanne I Adamkewicz
Susan K Lyman
Jason Chien
Xiaoming Li
Lixin Shao
Jeffrey D Bornstein
Original Assignee
Gilead Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6940375(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics Inc filed Critical Gilead Biologics Inc
Publication of CO6940375A2 publication Critical patent/CO6940375A2/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)
CO13301122A 2011-06-01 2013-12-27 Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo CO6940375A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21

Publications (1)

Publication Number Publication Date
CO6940375A2 true CO6940375A2 (es) 2014-05-09

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13301122A CO6940375A2 (es) 2011-06-01 2013-12-27 Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo

Country Status (24)

Country Link
US (3) US20120309020A1 (es)
EP (1) EP2714744A1 (es)
JP (3) JP2014523521A (es)
KR (1) KR20140048156A (es)
CN (1) CN103946241A (es)
AP (1) AP2013007285A0 (es)
AR (1) AR086657A1 (es)
AU (2) AU2012261883A1 (es)
BR (1) BR112013030682A2 (es)
CA (1) CA2837534A1 (es)
CL (1) CL2013003445A1 (es)
CO (1) CO6940375A2 (es)
CR (1) CR20130657A (es)
EA (1) EA201391627A1 (es)
EC (1) ECSP13013092A (es)
IL (1) IL229631A0 (es)
MA (1) MA35212B1 (es)
MD (1) MD20130098A2 (es)
MX (1) MX2013013905A (es)
PE (1) PE20141450A1 (es)
TW (1) TW201319572A (es)
UY (1) UY34115A (es)
WO (1) WO2012167181A1 (es)
ZA (1) ZA201308812B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
SI2185198T1 (sl) 2007-08-02 2015-04-30 Gilead Biologics, Inc. Inhibitorji LOX in LOXL2 ter njihova uporaba
WO2010080769A2 (en) 2009-01-06 2010-07-15 Arresto Biosciences, Inc. Chemotherapeutic methods and compositions
SG2014004816A (en) 2009-08-21 2014-03-28 Gilead Biologics Inc Catalytic domains from lysyl oxidase and loxl2
CA2789022A1 (en) 2010-02-04 2011-08-11 Gilead Biologics, Inc. Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
EP3348576A1 (en) * 2012-10-30 2018-07-18 Gilead Sciences, Inc. Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
WO2015187499A1 (en) 2014-06-03 2015-12-10 Gilead Sciences, Inc. Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
BR112016028750A2 (pt) * 2014-06-11 2017-11-14 Gilead Sciences Inc ?métodos para tratar, prevenir, ou melhorar pelo menos um sintoma associado e para diagnosticar e monitorar insuficiência cardíaca ou fibrilação atrial, inibidor da lisil oxidase ativa ou proteína lisil tipo oxidase, e, composição?
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
EP3423057A1 (en) 2016-03-04 2019-01-09 Gilead Sciences, Inc. Compositions and combinations of autotaxin inhibitors
WO2017177179A1 (en) 2016-04-08 2017-10-12 Gilead Sciences, Inc. Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
GB201704206D0 (en) 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
US20230152330A1 (en) * 2021-11-17 2023-05-18 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
SI2185198T1 (sl) * 2007-08-02 2015-04-30 Gilead Biologics, Inc. Inhibitorji LOX in LOXL2 ter njihova uporaba
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
BR112012008080A2 (pt) * 2009-08-21 2017-07-04 Gilead Biologics Inc ensaios de rastreamento in vivo.
CA2789022A1 (en) * 2010-02-04 2011-08-11 Gilead Biologics, Inc. Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
DE112012001731T5 (de) * 2011-05-10 2014-01-23 Borgwarner Inc. Turbolader mit variabler Turbinengeometrie

Also Published As

Publication number Publication date
MD20130098A2 (ro) 2014-06-30
EP2714744A1 (en) 2014-04-09
CA2837534A1 (en) 2012-12-06
EA201391627A1 (ru) 2014-08-29
JP2018049033A (ja) 2018-03-29
AU2016244254A1 (en) 2016-11-03
NZ618682A (en) 2016-04-29
MA35212B1 (fr) 2014-06-02
US20140206017A1 (en) 2014-07-24
ECSP13013092A (es) 2014-08-29
US20120309020A1 (en) 2012-12-06
WO2012167181A1 (en) 2012-12-06
ZA201308812B (en) 2014-08-27
IL229631A0 (en) 2014-01-30
AP2013007285A0 (en) 2013-11-30
JP2014523521A (ja) 2014-09-11
KR20140048156A (ko) 2014-04-23
JP2016164578A (ja) 2016-09-08
CN103946241A (zh) 2014-07-23
UY34115A (es) 2013-01-03
CR20130657A (es) 2014-05-16
AU2016244254B2 (en) 2018-10-18
US20170269085A1 (en) 2017-09-21
AU2012261883A1 (en) 2013-05-02
PE20141450A1 (es) 2014-11-06
TW201319572A (zh) 2013-05-16
BR112013030682A2 (pt) 2016-12-06
CL2013003445A1 (es) 2014-07-25
MX2013013905A (es) 2014-05-14
AR086657A1 (es) 2014-01-15

Similar Documents

Publication Publication Date Title
CO6940375A2 (es) Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo
CO6801741A2 (es) Derivados c4-monometil triterpenoides y sus métodos de uso
CL2016001556A1 (es) Anticuerpos anti-cd3 y métodos de uso
CL2014002086A1 (es) Anticuerpos cd47 y métodos de uso los mismos
CL2015000640A1 (es) Variantes de hppd y métodos de uso
CR20150380A (es) Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico
CO7020870A2 (es) Anticuerpos anti-htra1 y métodos de uso
CO6870033A2 (es) Compuestos terapéuticos y métodos de uso relacionados
CO7000747A2 (es) Anticuerpos anti-lrp5 y métodos de uso
BR112014028366A2 (pt) anticorpos anti-ly6e e imunoconjugados e métodos de uso
CO7030962A2 (es) Compuestos terapéuticamente activos y sus métodos de uso
CO7010834A2 (es) Compuestos terapéuticamente activos y sus métodos de uso
CO6870005A2 (es) Composición anti-cgrp y uso de las mismas
CO6801774A2 (es) Compuestos de benzotiazol y su uso farmacéutico
CO6862148A2 (es) Composiciones transdérmicas de ibuprofeno y métodos de uso de las mismas
CL2015001266A1 (es) Anticuerpos de antihemaglutinina y métodos de uso.
BR112014010175A2 (pt) unidades de filtro, componentes e recursos destas e métodos de uso e construção
BR112014002716A2 (pt) anticorpos anti-poliubiquitina e métodos de uso
BR112014012590A2 (pt) anticorpos anti-cd98 e métodos de uso dos mesmos
BR112013014119A2 (pt) novos moduladores e métodos de uso
CO7020907A2 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
SMT201600069B (it) Composizioni comprendenti 15-hepe e metodi d’uso delle stesse
BR112014000329A2 (pt) método de análise de distúrbios cardiovasculares e uso do mesmo
BR112014000049A2 (pt) pirrolotriazinas substituídas com hidroximelilarilo e sua utilização
BR112013022552A2 (pt) compostos de quinazolina substituídos com alcino e métodos de uso